These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7136384)

  • 1. [Apomorphine in dyskinesia and psychomotor agitation].
    Stoliarov GV; Markova OF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(8):97-102. PubMed ID: 7136384
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abnormal movements and shaking in geriatrics (author's transl)].
    Chabaud R; Guenoun M; Taddei JP; Guillou J
    Sem Hop; 1979 Mar 8-15; 55(9-10):465-9. PubMed ID: 38513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apomorphine and schizophrenia.
    Johns CA; Levy MI; Davis BM; Mohs RC; Kendler KS; Mathe AA; Trigos G; Horvath TB; Davis KL
    Psychopharmacol Bull; 1984; 20(1):103-7. PubMed ID: 6718635
    [No Abstract]   [Full Text] [Related]  

  • 4. [A therapeutic trial in a neurology department].
    Boulliat J
    Sem Hop; 1979 Feb 18-25; 55(7-8):375-8. PubMed ID: 35833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade by apomorphine of haloperidol-induced dyskinesia in schizophrenic patients.
    Gessa R; Tagliamonte A; Gessa GL
    Lancet; 1972 Nov; 2(7784):981-2. PubMed ID: 4116875
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modification of extrapyramidal signs by apomorphine associated with various dopaminergic antagonists].
    Pollak P; Gaio JM; Hommel M; Pellat J; Perret J; Chateau R
    Rev Neurol (Paris); 1982; 138(5):409-13. PubMed ID: 7146725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the anti-dyskinesia effect of apomorphine in man.
    Tolosa ES
    Neurol Neurocir Psiquiatr; 1976; 17(4):223-9. PubMed ID: 138800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apomorphine and diphasic dyskinesia.
    Durif F; Deffond D; Dordain G; Tournilhac M
    Clin Neuropharmacol; 1994 Feb; 17(1):99-102. PubMed ID: 8149366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Jankovic J
    Adv Neurol; 1983; 37():277-89. PubMed ID: 6574695
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new therapeutical approach in neurology (author's transl)].
    Divisia A; Girard-Madoux M
    Sem Hop; 1978 Nov 18-25; 54(41-42):1265-8. PubMed ID: 216105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of dopamine agonists in the treatment of schizophrenia.
    Corsini GU; Pitzalis GF; Bernardi F; Bocchetta A; Del Zompo M
    Neuropharmacology; 1981 Dec; 20(12B):1309-13. PubMed ID: 7033816
    [No Abstract]   [Full Text] [Related]  

  • 12. [Extrapyramidal hyperkinesia in the facial region].
    Hanzal F; Pragerová V
    Cesk Neurol Neurochir; 1981 Sep; 44(5):314-9. PubMed ID: 7307152
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
    Visanji NP; Gomez-Ramirez J; Johnston TH; Pires D; Voon V; Brotchie JM; Fox SH
    Mov Disord; 2006 Nov; 21(11):1879-91. PubMed ID: 16960862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "On-off" phenomena, dyskinesias and dystonias. Comparison of lisuride versus apomorphine acute treatment.
    Frattola L; Albizzati MG; Bassi S; Ferrarese C; Trabucchi M
    Acta Neurol Scand; 1982 Aug; 66(2):227-36. PubMed ID: 7136487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disorders.
    Jeste DV; Cutler NR; Kaufmann CA; Karoum F
    Biol Psychiatry; 1983 Sep; 18(9):1085-91. PubMed ID: 6640005
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease.
    Wenning GK; Bösch S; Luginger E; Wagner M; Poewe W
    Adv Neurol; 1999; 80():545-8. PubMed ID: 10410769
    [No Abstract]   [Full Text] [Related]  

  • 17. [Orofacial dyskinesia].
    Codeceira Júnior A
    AMB Rev Assoc Med Bras; 1980 Apr; 26(4):123-4. PubMed ID: 6107961
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of spontaneous dyskinesia in schizophrenia.
    Fenton WS
    J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding freedom from the frightful fidgets.
    Donaldson IM
    N Z Med J; 1992 May; 105(934):191-2. PubMed ID: 1352634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.